Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Shijiazhuang Yiling Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm primarily involved in the discovery, manufacturing, and distribution of medicinal products within China. Its operations are structured across two main divisions: Chemical and Biological Medicine, and the Health Industry sector. The company's therapeutic portfolio encompasses treatments for a wide array of conditions, including various cardiac ailments such as premature ventricular beats, sinus bradycardia, chronic heart failure, and comprehensive rhythm regulation. It also provides solutions for cold and respiratory illnesses, cardiovascular and cerebrovascular disorders, diabetes management, and oncology, among others. Products reach consumers through both traditional brick-and-mortar outlets and digital e-commerce platforms. Established in Shijiazhuang, China, in 1992, Shijiazhuang Yiling Pharmaceutical Co., Ltd. maintains its headquarters there.

CEO: Xiang Jun Wu - https://www.yiling.cn